서브메뉴
검색
Implementing Patient Education to Reduce SGLT- 2 Inhibitor Associated Euglycemic DKA in Patients With Heart Failure
Implementing Patient Education to Reduce SGLT- 2 Inhibitor Associated Euglycemic DKA in Patients With Heart Failure
상세정보
- 자료유형
- 학위논문 서양
- 최종처리일시
- 20260202103127
- ISBN
- 9798315704218
- DDC
- 610.73
- 저자명
- Boban, Laiby.
- 서명/저자
- Implementing Patient Education to Reduce SGLT- 2 Inhibitor Associated Euglycemic DKA in Patients With Heart Failure
- 발행사항
- [Sl] : The University of North Carolina at Chapel Hill, 2025
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2025
- 형태사항
- 42 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 86-11, Section: B.
- 주기사항
- Advisor: Kitzmiller, Rebecca;Bell-McClure, Elizabeth.
- 학위논문주기
- Thesis (D.N.P.)--The University of North Carolina at Chapel Hill, 2025.
- 초록/해제
- 요약Congestive heart failure (CHF) management is complicated by the risk of euglycemic diabetic ketoacidosis (EDKA) associated with sodium glucose cotransporter inhibitors (SGLT2i). CHF affects approximately 6.2 million people in the US, with high mortality rates despite guideline-directed medical therapy. While SGLT2i are highly effective in heart failure management, it also increases the risk of EDKA and other undesirable side effects. Patients' concern about side effects combined with the need to identify EDKA associated symptoms may be improved by facilitating patient awareness and self management. This project aimed improve patient SGLT2i education processes and the effect of education on patients' symptom identification and self-care to reduce the incidence of SGLT2i-related EDKA.The project was conducted in an academic medical center's cardiology clinic using the Iowa Model of Evidence-Based Practice to guide the implementation of patient education. The intervention included developing standardized patient education materials, integrating them into the electronic health record (EHR), and preparing providers through academic detailing. Baseline data collected from a purposive sample (n=50) of patient records showed no documented SGLT2i education. Post-intervention n=100 records were evaluated for education documentation. Five percent of patients received education, with two reporting symptoms and none admitted for EDKA. Provider engagement was limited, impacting the project's success.Improved patient education can enhance self-management and early symptom identification, reducing EDKA incidence. However, provider involvement and face-to-face education are crucial for effective implementation. Those involved in quality improvement must consider the barriers to influencing behavior, such as non-employee status and relying on email communication, as these may hinder provider engagement. Rather, improvement projects should include face to face engagement, employing a trusted and respected site champion and frequent feedback to providers. Systematic patient education on SGLT2i side effects is essential for reducing EDKA-related complications. Integrating education into the EHR and involving pharmacists in follow-up can improve patient outcomes when implemented effectively.
- 일반주제명
- Nursing
- 일반주제명
- Health education
- 일반주제명
- Health sciences
- 기타저자
- The University of North Carolina at Chapel Hill Nursing
- 기본자료저록
- Dissertations Abstracts International. 86-11B.
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008260126s2025 us c eng d■001000017357077
■00520260202103127
■006m o d
■007cr#unu||||||||
■020 ▼a9798315704218
■035 ▼a(MiAaPQ)AAI31938974
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a610.73
■1001 ▼aBoban, Laiby.
■24510▼aImplementing Patient Education to Reduce SGLT- 2 Inhibitor Associated Euglycemic DKA in Patients With Heart Failure
■260 ▼a[Sl]▼bThe University of North Carolina at Chapel Hill▼c2025
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2025
■300 ▼a42 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 86-11, Section: B.
■500 ▼aAdvisor: Kitzmiller, Rebecca;Bell-McClure, Elizabeth.
■5021 ▼aThesis (D.N.P.)--The University of North Carolina at Chapel Hill, 2025.
■520 ▼aCongestive heart failure (CHF) management is complicated by the risk of euglycemic diabetic ketoacidosis (EDKA) associated with sodium glucose cotransporter inhibitors (SGLT2i). CHF affects approximately 6.2 million people in the US, with high mortality rates despite guideline-directed medical therapy. While SGLT2i are highly effective in heart failure management, it also increases the risk of EDKA and other undesirable side effects. Patients' concern about side effects combined with the need to identify EDKA associated symptoms may be improved by facilitating patient awareness and self management. This project aimed improve patient SGLT2i education processes and the effect of education on patients' symptom identification and self-care to reduce the incidence of SGLT2i-related EDKA.The project was conducted in an academic medical center's cardiology clinic using the Iowa Model of Evidence-Based Practice to guide the implementation of patient education. The intervention included developing standardized patient education materials, integrating them into the electronic health record (EHR), and preparing providers through academic detailing. Baseline data collected from a purposive sample (n=50) of patient records showed no documented SGLT2i education. Post-intervention n=100 records were evaluated for education documentation. Five percent of patients received education, with two reporting symptoms and none admitted for EDKA. Provider engagement was limited, impacting the project's success.Improved patient education can enhance self-management and early symptom identification, reducing EDKA incidence. However, provider involvement and face-to-face education are crucial for effective implementation. Those involved in quality improvement must consider the barriers to influencing behavior, such as non-employee status and relying on email communication, as these may hinder provider engagement. Rather, improvement projects should include face to face engagement, employing a trusted and respected site champion and frequent feedback to providers. Systematic patient education on SGLT2i side effects is essential for reducing EDKA-related complications. Integrating education into the EHR and involving pharmacists in follow-up can improve patient outcomes when implemented effectively.
■590 ▼aSchool code: 0153.
■650 4▼aNursing
■650 4▼aHealth education
■650 4▼aHealth sciences
■653 ▼aCongestive heart failure
■653 ▼aEuglycemic diabetic ketoacidosis
■653 ▼aSodium glucose cotransporter inhibitors
■653 ▼aElectronic health record
■653 ▼aPatient education
■690 ▼a0569
■690 ▼a0680
■690 ▼a0769
■690 ▼a0566
■71020▼aThe University of North Carolina at Chapel Hill▼bNursing.
■7730 ▼tDissertations Abstracts International▼g86-11B.
■790 ▼a0153
■791 ▼aD.N.P.
■792 ▼a2025
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17357077▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
